SOPHiA GENETICS Partners with Jessa Ziekenhuis for Genomic Testing in Belgium
SOPHiA GENETICS has announced a significant collaboration with Jessa Ziekenhuis to advance genomic testing and oncology research in Belgium, announced in a press release. This partnership aims to bring cutting-edge genomic testing to cancer patients across the country.
Jessa Ziekenhuis, a major healthcare institution in Belgium, will integrate SOPHiA DDM™ into its pathology operations. This integration will standardize next-generation sequencing (NGS) workflows, enhancing efficiency and compliance with national guidelines. The hospital will implement six SOPHiA GENETICS applications tailored to its needs in solid tumors, hematologic malignancies, and liquid biopsy analysis.
The collaboration is expected to reduce hands-on time by 30-50%, cut costs by up to 25%, and accelerate testing turnaround times. Additionally, the SOPHiA DDM™ Dispatch feature will allow Jessa Ziekenhuis to share a NovaSeq sequencer with AZ Delta in Roeselare, Belgium, optimizing sequencing capacity and knowledge sharing through the Bridge Consortium.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis
Aignostics Opens Early Access to PathoSearch
MGI Tech Launches VisiOmics in Europe
Ultima Genomics Platform Selected for Precure's One Million Sample Dataset
Onymos and Vanta Diagnostics Report AI Lab Intake Results
Daily AI Brief: the AI news that matters, in your inbox.